Related Experiment Video
Updated: May 8, 2026
08:05
Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
Published on: December 12, 2011
External quality assessment schemes for immunoassays.
1UKNEQAS (Edinburgh), Department of Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
Methods in Molecular Biology (Clifton, N.J.)
|September 3, 2013
Summary
External quality assessment schemes (EQAS) monitor immunoassay performance by comparing lab results to target values. Well-designed EQAS assess analytical bias and precision, ensuring reliable data through established standards.
Area of Science:
- Clinical Chemistry
- Laboratory Medicine
- Assay Development
Background:
- External quality assessment schemes (EQAS) are crucial for monitoring immunoassay performance in clinical laboratories.
- These schemes complement internal quality control, enabling inter-laboratory comparisons and validation against target values.
Purpose of the Study:
- To highlight the importance of EQAS in assessing immunoassay analytical performance, focusing on bias and precision.
- To discuss the necessity for EQAS to adhere to national and international standards for data reliability.
- To present UK-based standards for EQAS and provide practical examples of their implementation.
Main Methods:
- Review of the principles and functions of external quality assessment schemes in immunoassaying.
- Analysis of how EQAS evaluate analytical bias and precision.
- Examination of error types commonly encountered in routine laboratory practice through EQAS data.
Main Results:
- EQAS effectively monitor immunoassay quality by comparing laboratory results to established targets.
- Well-designed schemes provide insights into analytical bias, precision, and common error patterns.
- Adherence to recognized standards is essential for participant confidence in EQAS data.
Conclusions:
- External quality assessment schemes are indispensable tools for ensuring the accuracy and reliability of immunoassay results.
- Implementing and adhering to robust national/international standards enhances the value and trustworthiness of EQAS.
- The described UK standards offer a framework for effective EQAS implementation and quality assurance in laboratory diagnostics.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:20Immunogold Electron Microscopy
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.